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Abstract 
Host and viral factors are important determinants in the pathogenesis of chronic HBV infection. To date, 
polymorphisms in several genes such as tumor necrosis factor-alpha, tripartite motif-containing 22, have been 
found to contribute to the risk of developing chronic HBV infection. The polymorphism in P2X7 gene has 
recently been demonstrated to be associated with susceptibility or resistance to infectious diseases. However, 
still no clear association between P2X7 gene and chronic HBV infection has been reported in the literature. 
Hence, this study aimed to investigate whether two polymorphisms of P2X7 (1513 and -762) genes confer 
susceptibility to chronic HBV infection. In a case control study, single nucleotide polymorphisms (SNPs) in 
P2X7 (1513, -762) genes were assessed using allele-specific PCR and PCR- RFLP. Thereafter, frequency of the 
genotypes and alleles in patients and control groups were compared and analyzed. For the 1513 loci, the 
heterozygosity (AC) was higher in patients (73; 50.0%) than controls (14; 23.3%) [P = 0.001, OR 3.286, 95% CI 
1.587-6885]. Furthermore, we found that the C allele was a risk factor for predisposition to chronic HBV 
infection (P = 0.006, OR 2.247, 95% CI 1.207-4.231). For the -762 loci, there were no significant statistical 
differences between the case and control groups in the genotype and allele frequencies (P > 0.05). In conclusion, 
in our study population, the P2X7 gene polymorphisms could be associated with susceptibility to chronic HBV 
infection. 
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1. Introduction 
Although a safe and effective vaccine is available, chronic hepatitis B virus (HBV) infections remain a major 
public health problem affecting around 400 million people in the world [1]. Fifteen percent to 40% of chronic 
HBV infection will eventually develop serious complications in term of cirrhosis, hepatic decompansation and 
hepatocellular carcinoma (HHC) [2]. Host and viral factors are important determinants in the pathogenesis of 
chronic HBV infection. To date, polymorphisms in several genes such as tumor necrosis factor-alpha (TNF-
alpha), tripartite motif-containing 22 (TRIM22), have been found to contribute to the risk of developing chronic 
HBV infection [3, 4]. The polymorphism in P2X7 gene has recently been demonstrated to be associated with 
susceptibility or resistance to infectious diseases [5]. The P2X7 encodes for the P2X7 receptor, a plasma 
membrane receptor which mediates adenosine triphosphate (ATP) induced autophagy [6]. Activation of P2X7 
by ATP causes immediate opening of a cation selective channel, permitting the influx of Ca2+ and Na+ and the 
efflux of K+. This process induces caspase cascade with resultant apoptosis and activation of phospholipase D, 
which promote phagosome-lysosome fusion, causing intracellular death of microorganisms [7]. There are more 
than 30 single-nucleotide polymorphisms (SNPs) in the P2X7 gene. The most common variant is 1513AC that 
produces a change of glutamic acid to alanine at residue 496 (Glu496 to Ala) in the C terminus, which impairs 
multiple P2X7 receptor functions [8]. Another polymorphism in the promoter region of -762TC has been 
suggested to alter P2X7 gene expression; however experimental evidence is lacking to find a clear association 
with infectious diseases [9]. The P2X7 receptor appears to be a necessary component of hepatitis B virus entry 
into susceptible cells during infection [10]. However, still no clear association between P2X7 gene and chronic 
HBV infection has been reported in the literature. Hence, this study aimed to investigate whether two 
polymorphisms of P2X7 (1513 and -762) genes confer susceptibility to chronic HBV infection. 
2. Materials and methods: 
2.1. Specimen collection: 
The study included 146 chronic HBV infected patients who were managed in hepatitis clinic, Azadi Teaching 
Hospital, Duhok from November 2011 to November 2012. Additionally, sixty healthy individuals were studied 
as controls. The study was approved by the ethics committee of Faculty of Medical Sciences, University of 
Duhok, Iraqi Kurdistan. Patient and control subjects were matched for age, gender, race and nationality. The 
frozen plasma specimens were shipped to Mycobacteriology Research Center (MRC), National Research 
Institute of Tuberculosis and Lung Diseases (NRITLD), Tehran, Iran for genomic DNA isolation and 
genotyping.  
2.2. DNA Isolation:  
Genomic DNA was extracted using the standard protocol with slight modifications [11]. Briefly, peripheral 
blood leukocytes (PBLs) were separated from two milliliters of the whole blood using RBC lysis buffer (0.155 
M NH4Cl, 0.01 M NaHCO3). Thereafter, PBLs was re-suspended in 500 μL of SE buffer (NaCl 3M, EDTA 
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0.5M, PH = 8), containing 40 μL of 10% SDS and 3 μL of 20 mg/mL of proteinase K. The suspension was 
incubated at 600°C for 30 minutes. After incubation, 200 μL of equilibrated phenol (PH = 8) was added to the 
mixture and centrifuged for 10 minutes at 12000 g. The aqueous phase was transferred to a new tube and the 
DNA was precipitated using cold propanol [11]. 
2.3. P2X7 Genotyping  
P2X7 gene polymorphism was studied using allele-specific PCR and PCR- RFLP. For P2X7 gene polymor-
phisms at -762, two outer primers [P2X73 (5'-GAAACAGGGCCCTGGGTCCTC-3', forward) and P2X74 (5'-
TGGTGGGGGTGGAGGGGC- 3', reverse)] and two inner primers [P2X75 (5'-
GGTGTCCCTCACTGAATAGGTCAAT-3', forward and P2X76 (5'-GGCAGTCCAACAAAGTTAGGTTTG-
3', reverse)] were used. For the -762°C allele, a 235 bp fragment was amplified using the outer forward (P2X73) 
and inner reverse (P2X76) primers. For the -762 T allele, a 186 bp fragment was amplified using the inner 
forward (P2X75) and outer reverse (P2X74) primers [12, 13]. The amplification was accomplished by an initial 
denaturation at 94°C for 5 minutes and 30 cycles at 95°C for 30 seconds, at 65°C for 30 seconds, at 72°C for 45 
seconds, followed by an extension at 72°C for 10 minutes. The amplified PCR products for CC, CT and TT had 
the following sizes 235 bp, 186+235 bp and 186 bp, respectively (Figure 1). For P2X7 gene polymorphisms at 
1513, the primers 5′ACTCCTAGATCCAGGGATAGCC3′ and 5′TACAGACGTGA GCCACGGT 3′ were used 
to amplify the 417 bp product (9, 10). The PCR product was digested with 4U enzyme of Hae II. The digested 
PCR products were run on 8% polyacrylamide gel, which was stained with ethidium bromide. The digest pattern 
for AA, AC and CC are as follows; 209 + 143 + 65 bp; 209 + 143 + 117 + 92 + 65 bp and 143 + 117 + 95 + 65 
bp, respectively (Figure 2). 
 
Figure 1: The -762 Amplified PCR Products, CC, CT and TT genotypes had 235 bp, 186+235 bp and 186 bp, 
respectively  
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Figure 2: Digest Pattern of 1513 P2X7 Gene. 
2.4. Statistical Analysis  
The frequency of the genotypes and alleles in patients and control groups were estimated by direct gene 
counting and then the data was analyzed using SPSS version 11 (SPSS Inc., Chicago, IL, USA). All P values 
were two tailed. A P value of less than < 0.05 was considered significant with 95% confidence interval (CI). 
3. Results: 
Three genotyping patterns were reported with 1513 and – 762 P2X7 polymorphisms; frequent homozygous 
genotype (wild type), infrequent heterozygous genotype and infrequent homozygous genotype (mutant type). 
For the 1513 loci, the heterozygosity (AC) was higher in patients (73; 50.0%) than controls (14; 23.3%) and the 
difference was statistically significant (P = 0.001, OR 3.286, 95% CI 1.587-6885). In contrast, the frequency of 
wild type (AA; 75.0% versus 49.3%) was significantly higher in control cases (P = 0.001, OR 0.324, 95% CI 
0.157-0.663). Furthermore, we found that the C allele was a risk factor for predisposition to chronic HBV 
infection (P = 0.006, OR 2.247, 95% CI 1.207-4.231). (Table 1).  
With regard to the -762 loci, the genotypes were TC (142, 97.2%); TT (2, 1.4%); CC (2, 1.4%) in the patient. 
Whereas, in the control group, the genotypes were TC (59, 98.3%); CC (1, 1.7%); TT (0, 0.0%). There were no 
significant statistical differences between the case and control groups in the -762 genotype and allelic 
frequencies (P > 0.05) (Table 2).   
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Table 1: Frequency distribution of the P2X7 - 1513 polymorphism in patients with chronic hepatitis B virus and 
in control subjects 
Genotype/Allele HBV Patient Control Odd ratio (95% CI) P value 
Genotype 
AA (frequent type) 72 (49.3%) 45 (75.0%) 0.324 (0.157-0.663) 0.001 
AC (heterozygote mutant) 73 (50%) 14 (23.3%) 3.286 (1.587-6.885) 0.001 
CC (homozygote mutant) 1 (0.7%) 1 (1.7%) 0.407 (0.011-15.167) 0.499 
Allele 
A 217 (74.3%) 104 (86.7%) 
2.247 (1.207-4.231) 0.006 
C 75 (25.7%) 16 (13.3%) 
 
Table 2: Frequency distribution of the P2X7 - 762 polymorphism in patients with chronic hepatitis B virus and 
in control subjects 
Genotype/Allele Patient HBV Control Odd ratio  (95% CI) P value 
Genotype 
TT (frequent type) 2 (1.4%) 0 (0.0%) inf (0.023-inf) 1.000 
TC (heterozygote mutant) 142 (97.2%) 59 (98.3%) 0.602 (0.025-5.895) 1.000 
CC (homozygote mutant) 2 (1.4%) 1 (1.7%) 0.819 (0.057-23.296) 1.000 
Allele 
T 146 (50.0%) 59 (49.2%) 
0.967 (0.618-1.513) 0.914 
C 146 (50.0%) 61 (50.8%) 
 
4. Discussion 
Hepatitis B virus is one of the most common viral infections affecting human being. Genetic variability in the 
host plays an important role in the pathogenesis of HBV infection. Several genes such as TNF-alpha (3), 
TRIM22 (4) and mannose-binding protein (MBP) [14] have been implicated in susceptibly to chronic HBV 
infection. Recently, P2X7 has been suggested to be essential component of HBV entry into susceptible 
hepatocytes [10]. Although P2X7 has been studied extensively in infectious diseases such as susceptibility to M. 
tuberculosis [5], limited studies were performed for HBV infection. In this regard, we have investigated the 
possible association between P2X7 gene polymorphism and susceptibility to chronic HBV infection, which may 
provide a novel finding in the field of HBV infection.  
In this study, we found a higher frequency of 1513AC genotype in patients (50.0%) than control (23.3%), which 
appeared to be a risk factor of developing chronic HBV infection. This finding supports previous studies, which 
indicates that appropriate expression and functionality of P2X7 could be a major contributor to the specific 
targeting of HDV and HBV to human hepatocytes [10]. Additionally, it is well known that the P2X7 receptor 
can mediate cell death, killing of infectious microorganisms, and regulation of the inflammatory cytokines [5]. 
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In contrast, the frequency of wild type (AA genotype) was significantly higher in control group (P = 0.001), 
which indicates its protective effect against chronic HBV infection.  Furthermore, we found that the 1513C 
allele is a risk factor for chronic HBV infection in our study population. Our observation was supported by other 
investigators who documented that the 1513C allele is a risk factor for the development of tuberculosis in the 
North Indian Punjabi population [15]. Hence, the present study demonstrates that polymorphism in P2X7 1513 
genotype can be used as a tool for identifying genetic susceptibility to chronic HBV infection.   
In our study, -762TC genotype was not associated with chronic HBV infection among the study population. 
Similar studies stated that P2X7 polymorphisms may or may not be associated with resistance or susceptibility 
to infectious diseases [16]. The polymorphism in -762 does not appear to correlate with altered receptor 
expression and hence does not suggest genetic factor for susceptibility to disease [17]. However, a study by 
Bahari et al. found a significant association between -762TC and tuberculosis [18]; whereas, other studies found 
a protective effect against tuberculosis [19]. With regard to -762 T allele, we did not find an association with 
chronic HBV infection. In contrast to this study, other researchers found a protective effect of the C allele at 
position -762 in the P2X7 promoter region, which supports a putative role for this gene in human immunity to 
infectious diseases [17]. We therefore concluded in this study that -762TC genotype and T allele are not 
associated risk factor of chronic HBV infection. 
To the best of our knowledge, this is the first report to investigate the relation of P2X7 gene polymorphisms 
with susceptibility to chronic HBV infection. In conclusion, the present study supports the P2X7 gene 
polymorphism could be associated with susceptibility to chronic HBV infection. Further prospective studies of 
these polymorphisms are warranted to identify people who are at high risk of developing chronic HBV 
infection. 
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